Literature DB >> 25391438

[Oral bioavailability of oncological preparations: the intake conditions are often decisive].

W Weitschies1.   

Abstract

The oral administration of pharmaceuticals plays an important role due to the many advantages, such as the simple administration and the associated high acceptance by patients. For modern oncological therapy in particular, the frequently encountered distribution of drug intake over morning, midday and evening is insufficient. Due to the sometimes highly significant food effect, the time of intake relative to mealtimes becomes of substantial importance. According to current knowledge the safest way to achieve as constant as possible resorption is to maintain strict rules with respect to intake times relative to food intake. Oral therapy with oncological drugs with pronounced food effects still raises the question how much the resorption is affected by simultaneous therapy with opioids.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25391438     DOI: 10.1007/s00120-014-3644-8

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  19 in total

1.  Oesophageal transport of solid dosage forms depends on body position, swallowing volume and pharyngeal propulsion velocity.

Authors:  E Osmanoglou; I R Van Der Voort; K Fach; O Kosch; D Bach; V Hartmann; A Strenzke; W Weitschies; B Wiedenmann; L Trahms; H Mönnikes
Journal:  Neurogastroenterol Motil       Date:  2004-10       Impact factor: 3.598

2.  The value meal: effect of food on lapatinib bioavailability.

Authors:  Atiqur Rahman; Richard Pazdur; Yaning Wang; Shiew-Mei Huang; Lawrence Lesko
Journal:  J Clin Oncol       Date:  2007-11-20       Impact factor: 44.544

3.  Oral anticancer drugs: back to square one.

Authors:  W Weitschies
Journal:  Clin Pharmacol Ther       Date:  2013-10       Impact factor: 6.875

4.  Standardization of clinical criteria required for use of the 12.5 millimeter barium tablet in evaluating esophageal lumenal patency.

Authors:  S H Gallo; S A McClave; L J Makk; S W Looney
Journal:  Gastrointest Endosc       Date:  1996-08       Impact factor: 9.427

Review 5.  Ageing and the gut.

Authors:  Edward Britton; John T McLaughlin
Journal:  Proc Nutr Soc       Date:  2012-11-12       Impact factor: 6.297

Review 6.  Drug absorption interactions between oral targeted anticancer agents and PPIs: is pH-dependent solubility the Achilles heel of targeted therapy?

Authors:  N R Budha; A Frymoyer; G S Smelick; J Y Jin; M R Yago; M J Dresser; S N Holden; L Z Benet; J A Ware
Journal:  Clin Pharmacol Ther       Date:  2012-06-27       Impact factor: 6.875

Review 7.  Drug-induced oesophageal disorders: pathogenesis, incidence, prevention and management.

Authors:  D Jaspersen
Journal:  Drug Saf       Date:  2000-03       Impact factor: 5.606

Review 8.  Sandimmun neoral pharmacokinetics: impact of the new oral formulation.

Authors:  D W Holt; E A Mueller; J M Kovarik; J B van Bree; F Richard; K Kutz
Journal:  Transplant Proc       Date:  1995-02       Impact factor: 1.066

Review 9.  Drug-induced esophagitis.

Authors:  G N Zografos; D Georgiadou; D Thomas; G Kaltsas; M Digalakis
Journal:  Dis Esophagus       Date:  2009-04-15       Impact factor: 3.429

10.  Effects of famotidine or an antacid preparation on the pharmacokinetics of nilotinib in healthy volunteers.

Authors:  Ophelia Q P Yin; Véronique Bédoucha; Tracey McCulloch; Cheng Zheng; Wei Zhou; Azra Hussaini; Steven Novick
Journal:  Cancer Chemother Pharmacol       Date:  2012-10-16       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.